Richard S. Yoon, MD
Director of Orthopaedic Research at Jersey City Medical Center, Barnabas Health
Use of ViviGen® Cellular Bone Allograft in Orthopaedic Trauma.
Do We Even Need Iliac Crest Anymore?
Thomas S. Roukis, DPM, PhD, FACFAS
Podiatric Medicine & Surgery Section
Gundersen Healthcare System
Dr. Roukis discusses his findings in a retrospective study of these two cellular bone allografts. He shares his thoughts and experience with both the lineage-committed bone cell product, ViviGen and the MSC-based cellular allograft Trinity.
Joseph Park, MD
MD, Foot & Ankle Trauma Surgeon, University of Virginia Medical Center
Dr. Park published the largest study to date examining the use of ViviGen for augmentation for fusion or ORIF in foot and ankle surgeries. Findings in this review suggest that ViviGen is capable of achieving high fusion rates, even in patients with comorbitities.
John Hall, MD, Flagstaff Bone and Joint
Cellular Bone Matrix and Fusion Outcomes in Challenging Patient Population.